Lars Rejnmark
#147,269
Most Influential Person Now
Researcher
Lars Rejnmark's AcademicInfluence.com Rankings
Lars Rejnmarkcomputer-science Degrees
Computer Science
#7486
World Rank
#7883
Historical Rank
Computational Linguistics
#1495
World Rank
#1511
Historical Rank
Machine Learning
#2771
World Rank
#2806
Historical Rank
Artificial Intelligence
#3067
World Rank
#3113
Historical Rank
Download Badge
Computer Science
Lars Rejnmark's Degrees
- PhD Computer Science Aarhus University
- Masters Computer Science University of Copenhagen
- Bachelors Computer Science University of Copenhagen
Similar Degrees You Can Earn
Why Is Lars Rejnmark Influential?
(Suggest an Edit or Addition)Lars Rejnmark's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial (2012) (605)
- Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk (2005) (519)
- Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research (2011) (478)
- Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe (2010) (389)
- Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture (2006) (376)
- Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus (2016) (337)
- Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study (2014) (318)
- Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. (2014) (305)
- Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications (2007) (300)
- European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. (2015) (296)
- Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium (2017) (250)
- Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population‐Based Cohort Study of 169,145 Cases During 1977–2001 (2009) (246)
- Fracture rates and risk factors for fractures in patients with spinal cord injury (1998) (236)
- Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper (2018) (234)
- Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes (2008) (232)
- Fracture risk associated with the use of morphine and opiates (2006) (225)
- Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark (2005) (222)
- Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia (2019) (220)
- Fracture Risk Associated with Use of Antiepileptic Drugs (2004) (219)
- Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study (2006) (212)
- Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss (2013) (206)
- Cardiovascular and renal complications to postsurgical hypoparathyroidism: A Danish nationwide controlled historic follow‐up study (2013) (204)
- Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. (2012) (203)
- Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data (2017) (194)
- Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement (2018) (193)
- Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. (2013) (193)
- Fracture risk is increased in Crohn's disease, but not in ulcerative colitis (2000) (192)
- Fracture risk is increased in epilepsy (1999) (187)
- Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture (2006) (182)
- Postsurgical Hypoparathyroidism—Risk of Fractures, Psychiatric Diseases, Cancer, Cataract, and Infections (2014) (179)
- Nephrolithiasis and renal calcifications in primary hyperparathyroidism. (2011) (167)
- The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study (2015) (163)
- The effect of adding PTH(1–84) to conventional treatment of hypoparathyroidism: A randomized, placebo‐controlled study (2011) (152)
- The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta‐Analysis of Randomized Controlled Trials (2015) (138)
- Hypertension Is a Risk Factor for Fractures (2009) (138)
- Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study (2012) (135)
- Influence of Hyper- and Hypothyroidism, and the Effects of Treatment with Antithyroid Drugs and Levothyroxine on Fracture Risk (2005) (131)
- Management of Hypoparathyroidism: Present and Future. (2016) (130)
- Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial. (2013) (129)
- Effects of vitamin D on muscle function and performance: a review of evidence from randomized controlled trials (2011) (125)
- Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. (2002) (122)
- Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. (2001) (116)
- Increased risk of osteoporotic fractures in patients with Cushing's syndrome. (2002) (115)
- Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. (2014) (114)
- Reduced Relative Risk of Fractures Among Users of Lithium (2005) (110)
- Effects of Simvastatin on Bone Turnover and BMD: A 1‐Year Randomized Controlled Trial in Postmenopausal Osteopenic Women (2004) (108)
- Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial (2015) (104)
- Fracture Risk in Perimenopausal Women Treated with Beta-Blockers (2004) (102)
- Loop Diuretics Increase Bone Turnover and Decrease BMD in Osteopenic Postmenopausal Women: Results From a Randomized Controlled Study With Bumetanide (2005) (102)
- Effects of PTH(1–84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial (2014) (101)
- Are Antiresorptive Drugs Effective Against Fractures in Patients with Diabetes? (2011) (100)
- Hip fracture risk in statin users—a population-based Danish case-control study (2004) (98)
- Has Mortality After a Hip Fracture Increased? (2007) (98)
- Fracture risk associated with systemic and topical corticosteroids (2005) (93)
- Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women (2012) (93)
- Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation (2018) (93)
- Intake of vitamin D and risk of breast cancer—A meta-analysis (2008) (93)
- Reduced Fracture Risk in Users of Thiazide Diuretics (2005) (91)
- Fracture Risk Associated with Parkinsonism and Anti-Parkinson Drugs (2007) (90)
- No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women (2004) (90)
- Vitamin D Insufficiency in Greenlanders on a Westernized Fare: Ethnic Differences in Calcitropic Hormones Between Greenlanders and Danes (2004) (88)
- Fracture risk is increased in patients with GH deficiency or untreated prolactinomas – a case‐control study (2002) (86)
- Selective Serotonin Reuptake Inhibitors and Other Antidepressants and Risk of Fracture (2008) (86)
- Fracture risk in patients treated for hyperthyroidism. (2000) (86)
- Maternal and infant vitamin D status during the first 9 months of infant life—a cohort study (2013) (79)
- Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. (2002) (78)
- Vitamin D content in human breast milk: a 9-mo follow-up study. (2016) (76)
- Simvastatin Does Not Affect Vitamin D Status, but Low Vitamin D Levels Are Associated with Dyslipidemia: Results from a Randomised, Controlled Trial (2009) (75)
- Statins decrease bone turnover in postmenopausal women: a cross‐sectional study (2002) (75)
- Reduced Prediagnostic 25-Hydroxyvitamin D Levels in Women with Breast Cancer: A Nested Case-Control Study (2009) (73)
- Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene (2011) (73)
- Corticosteroid use and risk of hip fracture: a population‐based case–control study in Denmark (2003) (73)
- Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study (2013) (73)
- Dose‐effect relations of loop‐ and thiazide‐diuretics on calcium homeostasis: a randomized, double‐blinded Latin‐square multiple cross‐over study in postmenopausal osteopenic women (2003) (72)
- Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo‐controlled trial (2016) (71)
- Decreased Fracture Risk in Users of Organic Nitrates: A Nationwide Case‐Control Study (2006) (71)
- Effects of thiazide‐ and loop‐diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study (2001) (71)
- Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. (2007) (70)
- Long‐Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case‐Control Study (2018) (70)
- PTH(1‐84) replacement therapy in hypoparathyroidism: A randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment (2013) (69)
- Fracture Risk Associated with Different Types of Oral Corticosteroids and Effect of Termination of Corticosteroids on the Risk of Fractures (2008) (69)
- A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk. (2014) (69)
- Increased Plasma Concentrations of Vitamin D Metabolites and Vitamin D Binding Protein in Women Using Hormonal Contraceptives: A Cross-Sectional Study (2013) (68)
- Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism (2016) (68)
- Fracture risk in patients treated with loop diuretics (2006) (66)
- Changes in 3‐dimensional bone structure indices in hypoparathyroid patients treated with PTH(1‐84): A randomized controlled study (2012) (64)
- Melatonin and the skeleton (2013) (63)
- Socioeconomic aspects of fractures within universal public healthcare: A nationwide case-control study from Denmark (2006) (63)
- Pseudohypoparathyroidism – epidemiology, mortality and risk of complications (2016) (61)
- Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus (2018) (60)
- Determinants of plasma PTH and their implication for defining a reference interval (2010) (59)
- Cobalamin and haptocorrin in human milk and cobalamin-related variables in mother and child: a 9-mo longitudinal study. (2013) (59)
- Role of Vitamin D in the Natural History of Inflammatory Bowel Disease (2018) (58)
- Increased Fracture Risk in Normocalcemic Postmenopausal Women with High Parathyroid Hormone Levels: A 16-Year Follow-Up Study (2011) (56)
- Fractures in patients with primary idiopathic hypothyroidism. (2000) (55)
- Use of organic nitrates and the risk of hip fracture: a population-based case-control study. (2009) (53)
- Investigations of the Anti-inflammatory Effects of Vitamin D in Adipose Tissue: Results from an In Vitro Study and a Randomized Controlled Trial (2013) (52)
- Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review (2015) (51)
- Effects of long‐term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover (2005) (50)
- Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women (2016) (50)
- No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women. (2004) (49)
- Statin but not Non-Statin Lipid-Lowering Drugs Decrease Fracture Risk: A Nation-Wide Case-Control Study (2006) (48)
- Osteoarthritis and Risk of Fractures (2009) (48)
- Fracture Risk Associated with Use of Nonsteroidal Anti-Inflammatory Drugs, Acetylsalicylic Acid, and Acetaminophen and the Effects of Rheumatoid Arthritis and Osteoarthritis (2006) (48)
- Fracture risk in users of oral anticoagulants: a nationwide case-control study. (2007) (47)
- High-dose treatment with vitamin A analogues and risk of fractures. (2010) (47)
- The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women. (2008) (47)
- Gastric and Esophagus Events Before and During Treatment of Osteoporosis (2010) (45)
- Vitamin D and its binding protein Gc: Long‐term variability in peri‐ and postmenopausal women with and without hormone replacement therapy (2006) (45)
- Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. (2008) (44)
- Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism (2009) (44)
- The Effect of High-Dose Vitamin D Supplementation on Calciotropic Hormones and Bone Mineral Density in Obese Subjects with Low Levels of Circulating 25-Hydroxyvitamin D: Results from a Randomized Controlled Study (2013) (43)
- Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. (2018) (42)
- Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study. (2012) (41)
- The Pathogenesis, Treatment and Prevention of Osteoporosis in Men (2012) (41)
- Plasma 1,25(OH)2D levels decrease in postmenopausal women with hypovitaminosis D. (2008) (41)
- Effect of Tamoxifen and Aromatase Inhibitors on the Risk of Fractures in Women with Breast Cancer (2008) (40)
- Biological variation of soluble CD163 (2003) (40)
- Emerging anabolic treatments in osteoporosis. (2011) (40)
- Effects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled Trial (2018) (40)
- The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial (2015) (39)
- Risk of Atrial Fibrillation Associated with Use of Bisphosphonates and Other Drugs Against Osteoporosis: A Cohort Study (2010) (39)
- Loss of life years after a hip fracture (2009) (39)
- Parathyroid response to vitamin D insufficiency: relations to bone, body composition and to lifestyle characteristics (2008) (38)
- Dietary Intake of Folate, but not Vitamin B2 or B12, Is Associated with Increased Bone Mineral Density 5 Years after the Menopause: Results from a 10-Year Follow-Up Study in Early Postmenopausal Women (2008) (38)
- Oral contraceptive use and risk of fractures. (2006) (37)
- Mapping the 3D orientation of nanocrystals and nanostructures in human bone: Indications of novel structural features (2020) (36)
- Managing vitamin D deficiency in inflammatory bowel disease (2019) (34)
- Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review (2019) (33)
- Hypercalcemia after discontinuation of long-term denosumab treatment (2016) (33)
- Anxiolytics and Sedatives and Risk of Fractures: Effects of Half-life (2008) (33)
- A single topical dose of erythropoietin applied on a collagen carrier enhances calvarial bone healing in pigs (2014) (32)
- MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders. (2019) (32)
- Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study (2017) (31)
- BMD improvements after operation for primary hyperparathyroidism (2012) (31)
- PTH replacement therapy of hypoparathyroidism (2012) (31)
- MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management. (2019) (31)
- Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study. (2013) (30)
- Fracture risk in patients with different types of cancer (2009) (30)
- Oral bisphosphonate use increases the risk for inflammatory jaw disease: a cohort study. (2012) (30)
- Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized‐controlled study on the effects of loop‐ and thiazide‐diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women (2001) (29)
- Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients (2020) (28)
- European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021) (2021) (28)
- Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared with population-based healthy sex-, age-, and season-matched controls. (2011) (27)
- Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia (2018) (26)
- ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of calcium metabolic disorders and osteoporosis (2020) (26)
- Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial. (2019) (25)
- Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism (2010) (25)
- Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study (2006) (24)
- Methotrexate, Azathioprine, Cyclosporine, and Risk of Fracture (2006) (24)
- Vitamin D status, physical performance and body mass in patients surgically cured for primary hyperparathyroidism compared with healthy controls ‐ a cross‐sectional study (2011) (24)
- Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT) (2019) (24)
- Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts (2019) (24)
- Clinical and Radiological Observations in a Case Series of 26 Patients with Fibrous Dysplasia (2014) (23)
- Bone Involvement in Primary Hyperparathyroidism and Changes After Parathyroidectomy. (2014) (23)
- Bone effects of glitazones and other anti-diabetic drugs. (2008) (23)
- Current Assays to Determine Free 25-Hydroxyvitamin D in Serum. (2017) (23)
- Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case‐Control Study (2018) (22)
- AP2S1 and GNA11 mutations - not a common cause of familial hypocalciuric hypercalcemia. (2017) (22)
- Muscle Function Is Impaired in Patients With “Asymptomatic” Primary Hyperparathyroidism (2014) (22)
- Health‐related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism (2018) (22)
- PTH treatment in hypoparathyroidism. (2011) (21)
- Health‐related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study (2018) (21)
- Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis (2011) (21)
- Vitamin D and Muscle Health: A Systematic Review and Meta‐analysis of Randomized Placebo‐Controlled Trials (2021) (20)
- Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates . (2018) (20)
- Quality of life in hypoparathyroidism (2018) (20)
- High Level of Agreement between Electronic and Paper Mode of Administration of a Thyroid-Specific Patient-Reported Outcome, ThyPRO (2016) (20)
- Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study (2018) (20)
- Effects of PTH and PTH Hypersecretion on Bone: a Clinical Perspective (2020) (19)
- No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial. (2015) (18)
- Fracture risk in very young women using combined oral contraceptives. (2008) (18)
- New and emerging antiresorptive treatments in osteoporosis. (2011) (18)
- Polymorphisms in the ALOX12 gene and osteoporosis (2011) (17)
- The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism. (2015) (17)
- PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism (2021) (17)
- Stroke in relation to use of raloxifene and other drugs against osteoporosis (2011) (17)
- [Strongly increasing incidence of hip fractures in Denmark from 1977 to 1999]. (2008) (16)
- Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial (2018) (16)
- Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study (2018) (16)
- Increased Trabecular Volumetric Bone Mass Density in Familial Hypocalciuric Hypercalcemia (FHH) Type 1: A Cross-Sectional Study (2014) (16)
- Hip fracture prevention: cost-effective strategies. (2001) (15)
- Muscle Performance and Postural Stability Are Reduced in Patients with Newly Diagnosed Graves' Disease. (2019) (15)
- Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis (2021) (15)
- 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival (2019) (15)
- Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, placebo-controlled trial (SYSDIET) (2014) (15)
- Renal complications in patients with chronic hypoparathyroidism on conventional therapy: a systematic literature review (2021) (15)
- Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study (2021) (15)
- Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy (2007) (14)
- Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: a case series. (2020) (14)
- Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT (2015) (13)
- Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR). (2013) (13)
- Postpartum vitamin D insufficiency and secondary hyperparathyroidism in healthy Danish women (2006) (13)
- The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial (2018) (13)
- Effects of supplemental vitamin D on muscle performance and quality of life in Graves' disease. A randomized clinical trial. (2020) (13)
- Cardiovascular drugs and bone. (2008) (12)
- Dental Findings in Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism: A Systematic Review (2018) (12)
- Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study (2007) (12)
- Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone (2015) (12)
- Hip Fracture Prevention (2012) (11)
- Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: A cohort study (2019) (11)
- 25(OH)D3 and 1.25(OH)2D3 inhibits TNF-α expression in human monocyte derived macrophages (2019) (11)
- Effects of Elevated Parathyroid Hormone Levels on Muscle Health, Postural Stability and Quality of Life in Vitamin D-Insufficient Healthy Women: A Cross-Sectional Study (2019) (11)
- Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study (2021) (11)
- Indoor, outdoor, and night work and blood concentrations of vitamin D and parathyroid hormone. (2018) (11)
- Fracture reducing potential of hormone replacement therapy on a population level. (2006) (11)
- Risk of fractures associated with treatment for benign prostate hyperplasia in men (2011) (11)
- No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and multiple sclerosis (2013) (11)
- Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series. (2018) (11)
- Polymorphisms of Muscle Genes Are Associated with Bone Mass and Incident Osteoporotic Fractures in Caucasians (2013) (11)
- Inverse Correlation at the Hip Between Areal Bone Mineral Density Measured by Dual-Energy X-ray Absorptiometry and Cortical Volumetric Bone Mineral Density Measured by Quantitative Computed Tomography. (2016) (10)
- Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels (2018) (10)
- Effect of calcium citrate vs calcium carbonate on elevated parathyroid hormone after Roux‐en‐Y gastric bypass. A double‐blinded, randomized trial (2018) (10)
- A pooled analysis of Vitamin D dose requirements for fracture prevention (2013) (10)
- Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome (2016) (10)
- Cardiovascular consequences of parathyroid disorders in adults. (2020) (10)
- Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo‐controlled trial (2018) (10)
- Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: Results from the Danish Osteoporosis Prevention Study (DOPS) (2006) (9)
- Bioavailable Testosterone Is Positively Associated With Bone Mineral Density in Male Kidney Transplantation Candidates (2018) (9)
- Circulating Levels of Muscle-Related Metabolites Increase in Response to a Daily Moderately High Dose of a Vitamin D3 Supplement in Women with Vitamin D Insufficiency—Secondary Analysis of a Randomized Placebo-Controlled Trial (2020) (8)
- Effects of Smoking on Severity of Disease in Primary Hyperparathyroidism (2010) (8)
- Three-Year Successful Cinacalcet Treatment of Secondary Hyperparathyroidism in a Patient with X-Linked Dominant Hypophosphatemic Rickets: A Case Report (2014) (8)
- Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism (2016) (8)
- Response rates to oestrogen treatment in perimenopausal women: 5-year data from the Danish Osteoporosis Prevention Study (DOPS). (2004) (8)
- Therapy of Hypoparathyroidism by Replacement with Parathyroid Hormone (2014) (8)
- Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study (2021) (8)
- Impact of infecting dose on severity of disease in an outbreak of food-borne Salmonella enteritidis. (1997) (7)
- Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review (2022) (7)
- Effect of 9 months of vitamin D supplementation on arterial stiffness and blood pressure in Graves’ disease: a randomized clinical trial (2019) (7)
- Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine. (2016) (7)
- Management of Primary Hyperparathyroidism (2022) (7)
- Effect of Intravenous Contrast on Volumetric Bone Mineral Density in Patients with Chronic Kidney Disease. (2016) (7)
- Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey (2022) (6)
- Parathyroid Hormone Therapy for Managing Chronic Hypoparathyroidism: A Systematic Review and Meta‐Analysis (2022) (6)
- Post-operative parathyroid hormone can be used as a predictor of normocalcaemia after total thyroidectomy. (2015) (6)
- Relationship Between Aldosterone and Parathyroid Hormone, and the Effect of Angiotensin and Aldosterone Inhibition on Bone Health (2015) (6)
- Clinical value of 11C-methionine positron emission tomography in persistent primary hyperparathyroidism—A case report with a mediastinal parathyroid adenoma (2018) (6)
- [Diuretics and osteoporosis]. (1998) (6)
- The cardiovascular system in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene. (2016) (6)
- Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross‐sectional study (2021) (6)
- Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop (2022) (5)
- Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss (2021) (5)
- Dental anomalies and orthodontic characteristics in patients with pseudohypoparathyroidism (2019) (4)
- Management of Hypoparathyroidism (2016) (4)
- The calcium-sensing receptor is essential for calcium and bicarbonate sensitivity in human spermatozoa. (2020) (4)
- Lower Leg Arterial Calcifications Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Hypoparathyroid and Pseudohypoparathyroid Patients (2021) (4)
- Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial (2022) (4)
- Unexplained High BMD in DXA-Scanned Patients is Generalized Throughout the Skeleton and Characterized by Thicker Cortical and Trabecular Bone (2015) (4)
- Opportunities for biomineralization research using multiscale computed X-ray tomography as exemplified by bone imaging (2021) (4)
- [Osteoporosis and fractures associated with drugs]. (2008) (3)
- SAT-LB72 Design of the PaTH Forward Phase 2 Trial of TransCon PTH, a Long-Acting PTH, in Patients With Hypoparathyroidism (2020) (3)
- Recombinant hormones in osteoporosis (2013) (3)
- The ageing endocrine system: Fracture risk after initiation of antihypertensive therapy (2013) (3)
- Response to “Calcium Supplements Increase Risk of Myocardial Infarction” (2015) (3)
- Vitamin D and the risk of dystocia: A case-control study (2020) (3)
- Expanding the spectrum of genetic variants in the calcium‐sensing receptor (CASR) gene in hypercalcemic individuals (2019) (3)
- Calcium supplements with vitamin D do not increase risk of cardiovascular diseases: Results from a randomized controlled trial (2011) (2)
- Are fractures due to anticoagulants or the disease necessitating the treatment? (2008) (2)
- Milk protein complexation enhances post prandial vitamin D3 absorption in rats. (2020) (2)
- T‐score differences and nonprogression in lumbar vertebrae as predictors of vertebral fractures (2019) (2)
- Maternal and infant vitamin D status during the first nine months of infant life — A cohort study (2012) (2)
- The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics (2021) (2)
- Multiple endocrine neoplasia phenocopy revealed as a co‐occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3 (2016) (2)
- Effects on Calcium Homeostasis of Changing PTH Replacement Therapy of Postoperative Hypoparathyroidism from Intact PTH to Teriparatide: A Case Series (2014) (2)
- Abstract 11380: Hormone Replacement Treatment in Early Postmenopausal Women Reduces Cardiovascular Events - A Randomized Controlled Study (2011) (2)
- Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves’ Disease Compared with Euthyroid Controls (2020) (2)
- Reduced muscle strenght in patients with long standing hypoparathyroidism compared to healthy controls (2010) (1)
- Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study (2022) (1)
- A Bone Perspective (2007) (1)
- [Denosumab--a new efficient osteoporosis therapy]. (2011) (1)
- The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1‐84): A retrospective cohort study (2022) (1)
- Reduced plasma 25-hydroxyvitamin D levels in Greendland inuits on a westernized fare compared to inuits on a traditional diet and Danes in Denmark. (2000) (1)
- The Diurnal Blood Metabolome and Effects of Vitamin D Supplementation: A Randomised Crossover Trial in Postmenopausal Women (2022) (1)
- PTH(1-84) substitution therapy in hypoparathyroidism: Effects on muscle cells and muscle function (2012) (1)
- Polymorphisms in the osteoprotegerin gene are associated with BMD and osteoporotic fractures (2010) (1)
- MON-522 Risk of Chronic Kidney Disease (CKD) and Its Progression in Patients with Chronic Hypoparathyroidism (HypoPT) (2019) (1)
- Change in estimated glomerular filtration rate in adult patients with chronic hypoparathyroidism treated with rhPTH(184) compared with a historical control cohort (2021) (1)
- Effects of Adding Chymosin to Milk on Calcium Homeostasis: A Randomized, Double-Blind, Cross-Over Study (2015) (1)
- National Osteoporosis Society - Tenth Scientific Conference (2004) (1)
- Effect of daily Vitamin D3 Supplementation on Muscle Health: An Individual Participant Meta-Analysis. (2022) (1)
- Molecular changes triggered in local osteoprogenitors at the onset of bone remodeling (2017) (1)
- Muscle function and quality of life in primary hyperparathyroidism (2013) (1)
- SAT-399 Baseline Characteristics from the Observational PARADIGHM Registry of Patients with Chronic Hypoparathyroidism (2020) (1)
- 3-hydroxybutyrate administration elevates plasma parathyroid hormone in a pilot human randomized, controlled, cross over trial. (2021) (1)
- The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study (2021) (1)
- Clinical Investigations Methotrexate, Azathioprine, Cyclosporine, and Risk of Fracture (2006) (1)
- C-11 methionine positron emission tomography scans improve the preoperative localization of pathologic parathyroid glands in primary hyperparathyroidism. (2021) (1)
- Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia. (2021) (1)
- Chronic hypercalcaemia in patients with FHH does not impair postural stability or muscle strength (2012) (0)
- Plasma triiodothyronine levels are positively associated with BMD and bone strength: a cross-sectional study (2013) (0)
- Benefits of 11C-methionine PET/MRI and intraoperative fluorescence in treating hyperparathyroidism (2020) (0)
- Short- and long-term effects of PTH treatment on intracortical bone remodeling with hypoparathyroidism (2022) (0)
- Post surgical hypoparathyroidism and the risk of fractures (2013) (0)
- How will my life with Graves’ disease be? Two years of serial, longitudinal follow-up of thyroid-related quality of life in patients with Graves’ disease (2020) (0)
- A haplotype of the ALOX12 gene is associated with changes in BMD and osteoporotic fractures (2010) (0)
- Reduced pre-diagnostic 25-hydroxyvitamin D levels in women with breast cancer (2009) (0)
- Risk of type 2 diabetes (T2D) in patients with chronic hypoparathyroidism (HypoPT): A retrospective cohort study (2019) (0)
- Design and topline results of TransCon PTH, a long-acting PTH, phase 2 trial in patients with hypoparathyroidism (2020) (0)
- Effects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled Trial (2018) (0)
- Efficacy and safety with TransCon PTH for adults with hypoparathyroidism through week 84 in the PaTH Forward trial (2022) (0)
- Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study (2014) (0)
- Risk of chronic kidney disease in adult patients with chronic hypoparathyroidism treated with rhPTH(184) compared with a historical control cohort (2021) (0)
- Effect of nine months of vitamin D supplementation on muscle performance in Graves' disease: a double-blinded, randomized clinical trial (2019) (0)
- Week 26 results from the PaTH Forward Open-Label Extension Trial Support TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism (2021) (0)
- FP417BONE TURNOVER MARKERS ARE NOT ASSOCIATED WITH BONE DENSITY OR FRAGILITY FRACTURES IN RENAL TRANSPLANT CANDIDATES (2015) (0)
- Conventional Treatment of Chronic Hypoparathyroidism (2015) (0)
- Relationship between fasting glucose, vitamin D and PTH in early postmenopausal women (2010) (0)
- Cortical density is lower in patients with Graves' disease compared to healthy controls (2016) (0)
- Review for "Postoperative Chronic Hypoparathyroidism and Quality of Life after Total Thyroidectomy" (2020) (0)
- TransCon PTH as a Hormone Replacement Therapy for Patients with Hypoparathyroidism: 6-Month Update from the PaTH Forward Open-Label Extension (2021) (0)
- Weigh the benefits of treatment against the increase in the risk of falls when using antidepressant therapy in the elderly (2010) (0)
- Heart rate and blood pressure, but not pulse wave velocity, are higher among adults with hereditary hypophosphatemia compared to healthy controls: a cross-sectional study (2023) (0)
- World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2019): Satellite Symposia Abstracts (2019) (0)
- MON-523 Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism (HypoPT) (2019) (0)
- What is the most efficient way to fortify food items with vitamin D? A randomised, multiple crossover study (2022) (0)
- Quality of life and psysical activicy in patients with non-surgical hypoparathyroidism and pseudohypoparathyroidism (2016) (0)
- European Registries for Rare Endocrine Conditions (EuRRECa): The use of an e-reporting tool for registering calcium and phosphate conditions (2021) (0)
- Effects of Adding Chymosin to Milk on Calcium Homeostasis: A Randomized, Double-Blind, Cross-Over Study (2014) (0)
- Bone mineral density in Danish patients with sarcoidosis (2022) (0)
- Risk of fractures in primary hyperparathyroidism: A systematic review and metaanalysis (2020) (0)
- Areal and volumetric BMD and bone geometry of the forearm in primary hyperparathyroidism and hypoparathyroidism compared with healthy controls - a cross sectional study (2010) (0)
- Abstract 18730: Vitamin D and Cardiovascular Mortality: An Individual Participant Data Meta-Analysis With Standardized 25-Hydroxyvitamin D (2016) (0)
- Effects of add on PTH(1–84) substitution therapy in hypoparathyroidism: Results from a double-blind randomised controlled study (2011) (0)
- The acute effects of milk intake on calcium homeostasis and cardiovascular outcome: A randomized crossover trial in postmenopausal women (2021) (0)
- Vitamin D and Muscle Health: A Systematic Review and Metaanalysis of Randomized Placebo-Controlled Trials (2021) (0)
- Polymorphisms of Muscle Genes Are Associated with Bone Mass and Incident Osteoporotic Fractures in Caucasians (2013) (0)
- Effects of vitamin d supplementation before and during pregnancy: A randomized controlled trial (2014) (0)
- Cardiovascular Events in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort (2021) (0)
- Serum Calcium Levels in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort (2021) (0)
- TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism: PaTH forward open-label extension trial week 26 results (2021) (0)
- Patients with surgically cured primary hyperparathyroidism have a reduced quality of life compared to population based healthy sex-, age-, and season- matched controls. Short title: Quality of life and primary hyperparathyroidism (2011) (0)
- CKD BONE DISEASE (2014) (0)
- Do folic acid, homocysteine and vitamin B 12 affect changes in bone mineral density postpartum? (2009) (0)
- Changes in treatment needs for chronic postoperative hypoparathyroidism during initiation of conventional treatment compared to stable phase of treatment (2021) (0)
- PTH treatment activates intracortical bone remodeling in patients with hypoparathyroidism (2017) (0)
- Risk of nephrolithiasis and nephrocalcinosis in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study (2019) (0)
- A randomized, double-blind, placebo-controlled trial of Vitamin D supplementation in patients newly diagnosed with graves' disease (2022) (0)
- Smoking protects against severity of disease in primary hyperparathyroidism (2009) (0)
- Changes in bone metabolism during pregnancy and breastfeeding: A controlled cohort study (2011) (0)
- Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial (2018) (0)
- FP768CHANGES IN BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN KIDNEY TRANSPLANT RECIPIENTS AND WAIT-LISTED CONTROLS; A PROSPECTIVE STUDY (2019) (0)
- Influence of food matrix delivery system on the bioavailability of vitamin D3: A randomized crossover trial in postmenopausal women. (2022) (0)
- 3 Comparison of the Incidence Rates of Thromboembolic Events Reported for Patients Prescribed Celecoxib and Meloxicam in General Practice in England Using Prescription-Event Monitoring (PEM) Data (174) (2003) (0)
- Similarities in postsurgical vs nonsurgical patients with hypoparathyroidism: post hoc analysis from recombinant human parathyroid hormone (rhPTH[1-84], parathyroid hormone rDNA) REPLACE study (2016) (0)
- [Osteoporosis--new therapeutic possibilities. The Danish Bone Society]. (2008) (0)
- Milk Products in the Treatment of Hypophosphatemic Rickets: A Pilot Study (2019) (0)
- Association of Serum Calcium and Phosphate With Incident Cardiovascular Disease in Patients With Hypoparathyroidism. (2023) (0)
- Cardiovascular events in adult patients with chronic hypoparathyroidism treated with rhPTH(184) compared with a historical control cohort (2021) (0)
- VDR polymorphisms do not affect PTH response to vitamin D levels (2011) (0)
- Abstract 15113: Vitamin D And Cardiovascular Outcome in Healthy Postmenopausal Women (2011) (0)
- Renal complications in patients with chronic hypoparathyroidism receiving conventional therapy: A systematic literature review (2020) (0)
- Vitamin D supplementation reduces pregnancy chances: a randomized, placebo-controlled trial (2016) (0)
- No beneficial effects of vitamin D supplementation in muscle function or quality of life in primary hyperparathyroidism: results from a randomized controlled trial (2014) (0)
- Analgesic Use in the Elderly (2017) (0)
- Effects on Calcium Homeostasis of Changing PTH Replacement Therapy of Postoperative Hypoparathyroidism from Intact PTH to Teriparatide: A Case Series (2014) (0)
- Erratum to: Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, controlled trial (SYSDIET) (2014) (0)
- MON-524 Risk of Decline in Estimated Glomerular Filtration Rate (eGFR) in Patients with Chronic Hypoparathyroidism (HypoPT) (2019) (0)
- A critical role of the bone marrow envelope in human bone remodeling. (2023) (0)
- Bone responses to chronic treatment of adult hypoparathyroid patients with PTH peptides (2018) (0)
- Author response for "Vitamin D and Muscle Health: A Systematic Review and Meta‐analysis of Randomized Placebo‐Controlled Trials" (2021) (0)
- Correction: Milk protein complexation enhances post prandial vitamin D3 absorption in rats. (2020) (0)
- Continuously treatment of hypoparathyroidism with PTH (2013) (0)
- Clinical and Radiological Observations in a Case Series of 26 Patients with Fibrous Dysplasia (2014) (0)
- Vitamin D insufficiency and hyperparathyroidism, general health and quality of life - a cross sectional study (2019) (0)
- Impaired quality of life and muscle function in patients with hypoparathyroidism/hypothyroidism compared with only hypothyroidism and controls (2016) (0)
- Polymorphisms of muscle genes are associated with incident osteoporotic fractures: The Danish osteoporosis prevention study (2010) (0)
- Pseudohypoparathyroidism in Denmark - Epidemiology, Morbidity And Mortality (2015) (0)
- Peripheral quantitative computed tomography (pQCT) in nine month old infants: Relations to gender and to maternal and infant plasma 25OHD and PTH levels (2012) (0)
- The Effect of High-Dose Vitamin D Supplementation on Calciotropic Hormones and Bone Mineral Density in Obese Subjects with Low Levels of Circulating 25-Hydroxyvitamin D: Results from a Randomized Controlled Study (2013) (0)
- Effect of vitamin D supplementation on cardiovascular indices in Graves' disease. A randomized clinical trial (2019) (0)
- LOW DOSES OF VITAMIN D WITH CALCIUM REDUCE THE RISK OF FRACTURES: PATIENT LEVEL ANALYSIS OF 68,500 PATIENTS FROM SEVEN MAJOR VITAMIN D TRIALS IN THE US AND EUROPE (2009) (0)
- Design and development of a European registry for parathyroid carcinoma cases within the scope of the European Registries for Rare Endocrine Conditions (EuRRECa) (2022) (0)
- The impact on calcium metabolism when replacing intact PTH with teriparatide treatment in patients with hypoparathyroidism (2014) (0)
- aBMD at the hip measured by DXA overestimate cortical vBMD assesed by QCT scans (2014) (0)
- Association of Calcium and Phosphate Levels with Incident Chronic Kidney Disease in Patients with Hypoparathyroidism: A Retrospective Case-Control Study (2022) (0)
- MON-526 Risk of Cardiovascular (CV) Conditions in Patients with Chronic Hypoparathyroidism (HypoPT) (2019) (0)
- Increased Trabecular Volumetric Bone Mass Density in Familial Hypocalciuric Hypercalcemia (FHH) Type 1: A Cross-Sectional Study (2014) (0)
- Bone Mineral Density Reduction Explains Buoyancy Adaptations in Notothenioids (2019) (0)
- The Effect of Treatment with Intact PTH on Undercarboxylated Osteocalcin and Measures of Energy Metabolism in Hypoparathyroidism: a Randomised, Placebo-Controlled Trial (2015) (0)
- Risk of sepsis, respiratory infections, and kidney or other genitourinary (GU) infections in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study (2019) (0)
- Review for "Vitamin D: Bolus is Bogus – a narrative review" (2021) (0)
- Pre‐existing diseases and use of loop diuretics may explain increased mortality in secondary hyperparathyroidism (2008) (0)
- Assessing variability of peripheral Quantitative Computed Tomography of tibia in 9 month old infants (2011) (0)
- Original research article Oral contraceptive use and risk of fractures (2006) (0)
- Milk, Cheese or Phosphate tablets in the treatment of Hypophosphatemic Rickets - A pilot Study (2017) (0)
- Change in Estimated Glomerular Filtration Rate in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort (2021) (0)
- Primary hyperparathyroidism and fracture probability (2022) (0)
- Abstract #1408044: Long-term Efficacy and Safety of TransCon PTH from Phase 2 PaTH Forward Trial in Adults with Chronic Hypoparathyroidism (2023) (0)
- Renal Complications in Hypoparathyroidism (2019) (0)
- The stability of 25-hydroxyvitamin D in human blood during different sampling and storage conditions (2009) (0)
- Effect of nine months of vitamin D supplementation on areal and volumetric bone mass density and bone architecture in graves’ disease: a double-blinded, randomized clinical trial (2020) (0)
- Risk of Chronic Kidney Disease in Adult Patients With Chronic Hypoparathyroidism Treated With rhPTH(1–84) Compared With a Historical Control Cohort (2021) (0)
- Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1–84): A Retrospective Cohort Study (2022) (0)
- Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study (2022) (0)
- Non-Surgical Hypoparathyroidism in Denmark - Epidemiology, Mortality and Complications (2015) (0)
- TransCon PTH, a long-acting PTH, in patients with hypoparathyroidism: Results of the phase 2 PaTH forward trial (2020) (0)
- Patients with surgically cured primary hyperparathyroidism have reduced quality of life compared to healthy age - and sex matched controls (2010) (0)
- Risk of myocardial infarction (MI), stroke, and other cardiovascular (CV) conditions in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study (2019) (0)
- Risk of chronic kidney disease (CKD) and CKD progression in patients with chronic hypoparathyroidism (HypoPT): a retrospective cohort study (2019) (0)
- The global, prospective, observational PARADIGHM registry for patients with chronic hypoparathyroidism was expanded to capture recombinant human parathyroid hormone, rhPTH(1-84), use under routine clinical care (2018) (0)
- CKD BONE DISEASE MP201 MAGNESIUM PROMOTES OSTEOGENESIS OF MESENCHYMAL STEM CELLS VIA NOTCH SIGNALING (2014) (0)
- Effects of add-on parathyroid hormone (PTH(1-84)) substitution therapy in hypoparathyroidism: results from 2.5 years of PTH treatment (2013) (0)
- Unexplained High BMD in DXA-Scanned Patients is Generalized Throughout the Skeleton and Characterized by Thicker Cortical and Trabecular Bone (2015) (0)
- OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism (2022) (0)
- The epidemiology of hypo- and pseudohypoparathyroidism in Denmark (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lars Rejnmark?
Lars Rejnmark is affiliated with the following schools:
